← Back to Search


Dry Needling for Shoulder Pain

Waitlist Available
Led By Jace A Brown, DPT
Research Sponsored by Texas Woman's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18-65 with unilateral nonspecific shoulder pain based on participants' self-reported pain level of greater than or equal to 2/10 on the Numeric Pain Rating Scale (NPRS) in last 24 hours
Non-traumatic origin of pain
Screening 3 weeks
Treatment Varies
Follow Up change from baseline shoulder range of motion immediately
Awards & highlights

Study Summary

This trial is studying whether a treatment for shoulder pain called dry needling can improve blood flow, motion and sensitivity in those with shoulder pain.

Who is the study for?
This trial is for individuals aged 18-65 with unilateral shoulder pain of non-traumatic origin, a self-reported pain level of at least 2/10, and at least one myofascial trigger point in the infraspinatus muscle. It excludes those with systemic joint diseases, red flags like fractures or tumors, cancer, pregnancy, anti-coagulant use, previous shoulder surgery, immunocompromised conditions (like diabetes), repeated infections or neurological disorders.Check my eligibility
What is being tested?
The study tests whether dry needling can improve blood flow in the infraspinatus muscle using color Doppler imaging. Participants will also be assessed for changes in shoulder motion and pressure sensitivity post-treatment compared to sham dry needling.See study design
What are the potential side effects?
Potential side effects from dry needling may include temporary soreness or bruising at the needle site. There's also a low risk of bleeding or infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am between 18 and 65 years old and have shoulder pain rated at least 2/10.
My pain is not due to an injury.
I have a painful spot in my shoulder muscle that hurts when pressed.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline psv immediately
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline psv immediately for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
End Diastolic Velocity (EDV)
Peak Systolic Velocity
Pulsatile Index (PI)
+1 more
Secondary outcome measures
Pain Pressure Thresholds (PPT)
Shoulder Range of Motion

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Dry NeedlingExperimental Treatment1 Intervention
Individuals with shoulder pain will receive dry needling to the two to four most tender points in the infraspinatus based on examiner palpation
Group II: Sham Dry NeedlingPlacebo Group1 Intervention
Individuals with shoulder pain will receive sham dry needling to two points in the muscle belly of the infraspinatus near the insertion and below the midpoint of the spine of the scapula

Find a Location

Who is running the clinical trial?

Texas Woman's UniversityLead Sponsor
86 Previous Clinical Trials
5,840 Total Patients Enrolled
3 Trials studying Shoulder Pain
154 Patients Enrolled for Shoulder Pain
Jace A Brown, DPTPrincipal InvestigatorTexas Woman's University

Media Library

Dry Needling (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05596240 — N/A
Shoulder Pain Research Study Groups: Dry Needling, Sham Dry Needling
Shoulder Pain Clinical Trial 2023: Dry Needling Highlights & Side Effects. Trial Name: NCT05596240 — N/A
Dry Needling (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05596240 — N/A
~7 spots leftby Oct 2024